The NFL is partnering with Canadian researchers on a clinical trial to test the safety and efficacy of CBD for pain management and neuroprotection from concussions—key issues for many football players who experience injuries as part of the game. For this study, researchers at the University of Regina will collaborate with NFL, aiming to identify the “optimal” dose of cannabidiol that can be safely consumed on a daily basis. Participants who receive the CBD will start with five milligrams per kilogram of body weight, and that will be gradually increased to 30 milligrams per kilogram.
This study is designed to investigate anti-inflammatory and neuroprotection of the CBD formulation to determine whether it can be used on a daily basis safely during the periods of intensive exercise (resistance) training during the off-season prior to competition. NFL has committed hundreds of thousands of dollars to research investigating the therapeutic potential of the non-intoxicating cannabinoid in recent years, including funding for studies on CBD as a potential opioid alternative.
